Company: LGN
Filing Date: 2025-07-15
Form Type: DRS/A
Source: 0000950123-25-006399
Chunk: 89

Company: Legence Corp.
Filing Date: 2025-07-15
Form: DRS/A
Chunk 89
---
 offering, there will be only
publicly traded shares of Class A Common Stock held by our public stockholders ( shares of Class A Common Stock if the underwriters exercise in full their option to purchase additional shares of
Class A Common Stock). After this offering, our Sponsor will beneficially own (i) shares of Class A Common Stock, representing an aggregate % of outstanding shares of our Class A Common Stock (or %
of outstanding shares of our Class A Common Stock if the underwriters exercise in full their option to purchase additional shares of Class A Common Stock and after giving effect to the application of the net proceeds therefrom), and (ii)
shares of our Class B Common Stock (or shares of Class B Common Stock if the underwriters exercise in full their option to purchase additional shares of Class A Common Stock and after giving
effect to the application of the net proceeds therefrom), representing an aggregate % of outstanding shares of our Class B Common Stock (or % of outstanding shares of our Class B Common Stock if the underwriters exercise in
full their option to purchase additional shares of Class A Common Stock and after giving effect to the application of the net proceeds therefrom). Subject to certain limitations and exceptions, our Sponsor may exchange their LGN Units (together
with shares of Class B Common Stock) for shares of Class A Common Stock (on a one-for-one basis, subject to conversion rate adjustments for stock splits, stock
dividends and reclassification and other similar transactions). We do not know the extent to which investor interest will lead to the development of an active trading market or how liquid that market might become. If an active trading market does
not develop, you may have difficulty reselling any of our Class A Common Stock at or above the initial public offering price. Additionally, the lack of liquidity may result in wide bid-ask spreads,
contribute to significant fluctuations in the market price of the Class A Common Stock and limit the number of investors who are able to buy the Class A Common Stock.

The initial public offering price for the Class A Common Stock offered hereby will be determined by discussions between us and the
representatives of the underwriters and may not be indicative of the market price of the Class A Common Stock that will prevail in the trading market. Consequently, you may not be able to sell shares of our Class A Common Stock at prices
equal to or greater than the price paid by you in this offering.

54

Confidential Treatment Requested by Legence Corp. Pursuant to 17 C.F.R